Nio and XPeng gain following Q2 deliveries announcements Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Spero Therapeutics (SPRO) up 21% after announcing that Pfizer (PFE) has made a $40M equity investment in the company as part of the Pfizer Breakthrough Growth Initiative
- Nio (NIO) up 3% after announcing that it delivered 8,083 vehicles in June and 21,896 vehicles in Q2, both records for the company
- XPeng (XPEV) up 4% after announcing that it delivered 6,565 Smart EVs in June and 17,398 vehicles in Q2
- Jazz Pharmaceuticals (JAZZ) up 5% after announcing the FDA approval of Rylaze for use as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and adult patients one month and older who have developed hypersensitivity to E. coli-derived asparaginase
UP AFTER EARNINGS -
- Walgreens Boots Alliance (WBA) up 1%
- Acuity Brands (AYI) up 4%
DOWN AFTER EARNINGS -
- Micron (MU) down 2%
- McCormick (MKC) down 1%
LOWER -
- Novocure (NVCR) down 8% after announcing final results from its phase 2 pilot HEPANOVA trial in liver cancer testing the safety and efficacy of Tumor Treating Fields together with sorafenib for the treatment of advanced hepatocellular cancer
- CureVac (CVAC) down 15% after releasing Phase 2b/3 study data of its COVID-19 vaccine candidate, with overall vaccine efficacy reported at about 48%
Symbols:
SPRO NIO XPEV JAZZ WBA MU NVCR CVAC AYI MKC PFE Keywords: Fly Intel, Wall Street, Top Stories, Stocks